≥30 kg/m
2 . Waist circumference (WC) was deemed to be located at the midpoint between the lowest rib and the iliac crest, and was measured with participants lightly clothed using a flexible, inelastic belt-type tape. Abdominal obesity was defined as WC >102 cm in men and >88 cm in women. Information on physical activity was obtained with the questionnaire used in the EPIC study that combines physical activity at work and at leisure time, 20 and physical inactivity was defined as being inactive or moderately inactive. Participants also reported if they had ever being diagnosed with cardiovascular disease (CVD), diabetes, or hypertension. Medication use was collected by a face-to-face interview and verified against drug packaging during the home visits.
Blood pressure measurement
BP was measured by certified examiners using standardized procedures and conditions.
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Casual BP was measured with validated automatic devices (Omron M6) and appropriate sized cuffs. BP was determined three times at 2-minute intervals, after resting 5 minutes in a seated position. In the analyses, casual BP was calculated as the mean of the last two of the three readings.
Thereafter, 24-h ABPM was performed with a validated automated non-invasive oscillometric device (Microlife WatchBPO3 monitor, Microlife Corp, Switzerland), 22 programmed to register BP at 20-min intervals during the day and at 30-min during the night for the 24-h period. Appropriate cuff sizes were used. The majority of registries were performed on working days and the patients were instructed to maintain their usual activities but keeping the arm extended and immobile at the time of cuff inflation. The staff of the study returned to the patients' homes for device removal the following day. Valid ABPM registries had to fulfill a series of pre-established criteria, including 24-h duration and at least 70% successful recordings of systolic BP (SBP) and diastolic BP (DBP) during the day and night. 23, 24 Daytime and night-time periods were defined individually according to the patient's self-reported time of going-to-bed and getting-up.
Based on casual BP, hypertension was defined as mean SBP ≥140 mm Hg, DBP ≥90 mm Hg, or currently taking prescribed antihypertensive medication. [23] [24] [25] [26] Treated hypertensive was defined as an affirmative answer to the following questions: "Were you prescribed an antihypertensive medication by your physician?" and "Are you currently taking this BP medication?" Among treated hypertensives, BP control was defined as SBP <140 and DBP <90 mm Hg, thresholds that were also used for identifying hypertension in untreated subjects. We chose this threshold since it corresponds to the universal definition of hypertension and BP target for all ages at the time of the survey, 25, 26 it is used in many population surveys, [15] [16] [17] 27 and has a consensus ABPM equivalent (130/80 mmHg for 24-h BP). [23] [24] [25] Accordingly, ambulatory hypertension was defined as mean 24-h SBP ≥130 mmHg, DBP ≥80 mmHg, or on current BP medication; this same value also corresponded to the treatment target. Treatment-eligible hypertension was defined as either BP above target or at goal BP under drug treatment.
Statistical analyses
A total of 1047 individuals with ≥70% valid ABPM readings and complete information on study´s variables were used for analysis (78.8% of all with available ABPM).
We examined the relationship between casual and ambulatory BP through scatterplots supplemented with Bland-Altman plots. 28 Then we classified individuals according to casual BP using two criteria: 1) BP categories (720 subjects with hypertension and 327 with normotension), and 2) antihypertensive drug treatment (514 treated hypertensives and 533 untreated subjects; the latter including 206 untreated hypertensives and 327 normotensives). We then calculated the percentage (and 95% confidence intervals) of hypertensive subjects according to casual BP and to ABPM. Likewise, we calculated the percentage of subjects at BP goal according to casual BP and ABPM thresholds. [23] [24] [25] [26] Although strictly speaking only treated subjects could meet BP goals, from a practical viewpoint untreated subjects were included in this definition since they could also be within (rather than achieve) the normal BP range. Hypertensive patients were older, with higher prevalence of obesity and diabetes than normotensives. Also, treated hypertensives were older, with higher mean BMI and higher frequency of obesity, diabetes and previous history of CVD than untreated subjects (Table 1) . Mean casual and ambulatory SBP was higher in treated hypertensives than untreated participants (Table 1) . However, compared with the 514 treated hypertensive patients, the 206 untreated hypertensive patients had higher mean casual and ambulatory BP (data not shown). Among treated patients, 36% were taking angiotensin-receptor blockers, 23.9% ACE inhibitors, 17.3% calcium-channel blockers, 20% diuretics, 20.8% betablockers, and 4.7% alpha-blockers. Overall, 56% of treated patients were on monotherapy, 31% on 2 drugs, and 13% on 3 or more drugs.
RESULTS

Sample characteristics
Relationship between casual and ambulatory blood pressure
The scatter diagrams showed only moderate fitting to the regression line ( between casual and daytime SBP was 9.9 mmHg (1.6 for DBP).
Prevalence of hypertension according to blood pressure measurement
Based on only casual BP, the prevalence of hypertension was 68.8% (95% CI 66.0-71.6%),
and it was 62.1% based on 24-h ABPM (95% CI 59.2-65.0%) ( Table 2 ). The difference in hypertension prevalence between casual and 24-h BP generally remained across sociodemographic and cardiovascular risk factors like education level, obesity, physical inactivity, diabetes, smoking, and previous CVD (data not shown).
Blood pressure reclassification according to treatment status
A total of 206 (38.6%) untreated participants were above casual BP normal value, and 103 of these (19.3% of all subjects) were above the 24-h normal value. Thus, 103 or 19.3% of all participants were above normal values under casual BP measurement and would be reclassified as at normal BP under ABPM (Table 3) . Similarly, 245 (47.7%) treated subjects were above casual BP goal, and 121 of these (23.5% of all subjects) were above the 24-h goal. Thus, 124 (24.1% of all subjects) were above the goal under casual BP and would be reclassified as at BP goal under ABPM (Table 3) .
Likewise, 33 (6.2%) untreated participants had normal BP according to casual BP but would be reclassified as at above normal BP with ABPM, and 41 (8.0%) treated patients were at goal under casual BP and would be reclassified as at above BP goal with ABPM (Table 3) .
Total reclassifications were 21.7% from above normal casual BP to at normal 24-h BP, and 7.1% from at normal casual BP to above normal 24-h BP (Table 3) . Lastly, 522 or 49.9% of all subjects (55.2% of untreated and 44.4% of treated) were within both normal casual and ambulatory BP ranges (Table 3) .
Casual and 24-h blood pressure control
Treatment eligible hypertension and blood pressure control
The 720 casual-BP-based hypertensives and the 650 24h-BP-based hypertensives were eligible for treatment. BP control among these patients with treatment-eligible hypertension increased from 37.4% (95% CI 33.9%-40.9%) under casual BP target to 54.1% (95% CI 50.3%-57.9%) under 24-h ABPM target (absolute difference 16.7%, p<0.01) (Figure 3) .
Lastly, among subjects with BP above goal under casual BP target, 206 (45.7%)
were not receiving antihypertensive medication treatment. Among subjects with BP above goal under the 24-h ABPM target, 136 (45.6%) were not treated with antihypertensive medication.
Sensitivity analyses
Under the 140/85 mmHg casual BP threshold only for people with diabetes, main results remained materially unchanged (data not shown). Results were also similar when comparing casual BP (140/90 threshold) with ambulatory daytime target (135/85 mmHg) ( was practically identical to that based on main thresholds used (6.7%), and the total reclassification proportions would then be 26.0% and 3.6%, close to those from the main targets considered (Table 4) ; however, control among treatment-eligible patients was much higher, thus a much larger number of patients would be seen as reaching target.
DISCUSSION
This contemporary population-based study has comprehensively quantified the proportion of older patients potentially affected by ABPM targets. It has shown that, the impact of using ABPM is appreciable. First, the prevalence of hypertension would be overestimated had BP status been assessed with casual BP instead of ABPM. Specifically, 6.7% or one in 15 hypertensive patients according to casual BP would not be considered hypertensive had ABPM been used, suggesting a considerable overdiagnosis when clinic BP is used alone.
Extrapolating this 6.7% reduction to the older population of Spain in 2012, 31 it would represent a reduction of approximately 700,000 older subjects classified as needing BP medication (7.5 million under casual BP and 6.8 million under the 24-h BP targets). In addition, the percentage of patients with treatment-eligible hypertension who met BP goals increased by 16.7% in absolute terms (one in 6 patients, or about 900,000 patients).
Also, there was a considerable gap between the percentage of hypertensive patients at BP goal with ambulatory versus casual BP (16.1% or one additional hypertensive actually controlled in 6 treated patients). This conveys an optimistic message to physicians because when BP is measured more accurately, the degree of BP control achieved is clearly higher.
However, overall only half of all subjects were at BP goal under both BP measurement techniques, which is important since some studies have shown that the ability to predict mortality was increased by the combination of in-office and out-of-office BP values.
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Discordance between casual and ambulatory BP. Clinical and public health implications
Given the scarce concordance between casual and ambulatory BP, two main BP phenotypes emerge: white-coat (only casual BP above goal) and masked hypertension (only 24-h BP above goal) among untreated patients, and "office or casual resistance" and masked uncontrolled hypertension among treated patients. 4, 19, [23] [24] [25] 322 Nevertheless, we prefer to place the emphasis on patient reclassification to better appreciate the impact of using ABPM. One in 5 untreated subjects would be reclassified as not treatment-eligible, a concept that is consistent with the generally benign prognosis and conservative therapeutic approach in subjects with only casual BP elevated, at least in the absence of additional risk factors. 23, 25, 34 Likewise, one in 4 treated patients would be reclassified as BP at goal, and thus might not need treatment intensification. Methodological differences aside, these proportions are moderately higher than those in other population-based studies, 8 Overall, the number of subjects who were still considered to have above-goal BP (28.5% of all subjects) outnumbered the number of subjects reclassified as at goal under ABPM target (21.7%), and almost half of subjects with BP above goal under either casual or 24-h targets were untreated.
All this supports the NICE statement on offering ABPM for the diagnosis of hypertension after an initial raised reading in the clinic; ABPM would reduce misdiagnosis, ensure the right people are treated with antihypertensives, and reduce the number of patients treated for hypertension. 14,39 Although not universally accepted, 24 this could save costs since the extra costs from ABPM are offset by cost savings from better targeted treatment. 40 Furthermore, ABPM is well tolerated by people, including the elderly. 41, 42 Likewise, given these and other advantages of ABPM, some authors have proposed that the US Centers for Disease Control and Prevention include ABPM in the NHANES and that the US Food and Drug Administration (FDA) requires the use of ABPM as the gold standard for recording BP in randomized clinical trials. 43 Yet it is well known that ABPM is not available to most patients with hypertension, and we might as well wonder if it will not take a medico-legal challenge to make the technique universally available.
Methodological aspects
Given that this study was not strictly representative of the general older population of Spain, Of note, like in some other population surveys, 15-17 casual BP was not measured in the office but in subjects´ home, thus probably diminishing a reaction alarm and giving more realistic estimates. However, only a few BP readings were taken on a single occasion by observers which were not familiar to the subjects. No doubt other methods such as automated office BP monitoring with the patient alone can also minimize anxiety-related increases in BP, 44 and some population studies have used office, home, and ABPM measurements. 8, 9 Nevertheless, the present study was specifically focused on the direct comparison between the two out-of-office BPs individually, which may provide a more accurate classification of the BP status. Given that the present analyses suggest that casual BP measurements are a biased estimate of ambulatory BP, it is likely that having multiple BP measurements would have not minimized the beneficial impact of ABPM. Lastly, antihypertensive therapy was based on the participant´s declaration and therefore may be imprecise. Also, treatment adherence was not assessed, but it has been reported to be relatively high in Spain (68%).
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Conclusions
We estimated that the application of ABPM would potentially reduce the number of older 
